Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Jeff Parent B. Eng. FCSI CIM
Alexion PharmaceuticalsALXNTOP PICKMar 09, 2007
Top Short There's a small problem with this stock. Around March 20 they are going to be releasing some news that might have major influence on the stock. Had a very long base around $34 and thinks this is where the stock is heading. Volumes are not large. Use a $1 trailing stop.
$37.08
Stock price when the opinion was issued
$182.90
As of Jul 20, 2021. Market Open.
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
COMMENT
Biotech can be a big win or a big loss. A lot of companies have binary outcomes, their product either works or it doesn’t. This company recently had a significant disappointment. US investors are not very sympathetic to these types of situations. They shoot first and ask questions later. If you want to own biotech, he would suggest you own a tech with lots of different products, or buy an ETF that gives you a basket. This one is a broken stock.
biotechnologypharmaceutical
